January 22, 2023
Biden Risks Legacy by Choosing Zients as Chief of Staff
As a businessman, Jeffrey Zients embodied much of the corporate misconduct the executive branch ought to be cracking down on.
April 25, 2022
2020 Election/TransitionClimateEthics in GovernmentExecutive BranchJeff ZientsRevolving Door
What You Need To Know About The Contenders For Biden’s Next Chief Of Staff
Nearly halfway through President Biden’s second year in office, with midterms on the horizon and senior staff either burning out or eager to sell out, “Transition 2.0” — the rapid departure of said senior staff with an influx of new personnel — is growing closer. One position we’re keeping a close eye on is Biden’s next Chief of Staff. Currently filled by Ron Klain, this is Biden’s de facto power broker. He helps the president make decisions and acts as a gatekeeper for the many, MANY forces, good and bad, who’d like to influence the president.
April 04, 2022 | The American Prospect
The Corporate Past Of Jeffrey Zients
Over the span of two decades, the health care companies that Zients controlled, invested in, and helped oversee were forced to pay tens of millions of dollars to settle allegations of Medicare and Medicaid fraud. They have also been accused of surprise-billing practices and even medical malpractice.
January 13, 2022 | The American Prospect
Fire Jeff Zients
Biden’s COVID czar has gone from ‘Mr. Fix-It’ to grim reaper, steering the administration’s pandemic response to catastrophic lows.
December 22, 2021 | Common Dreams
Free At-Home Tests Are a Start, But Biden Must Move Faster and Go Bigger to End Pandemic
The Covid-19 threat will not simply go away—especially when addressed with half measures. The administration must use its authority under the Defense Production Act much more wisely and aggressively.
September 29, 2021 | The American Prospect
How to Vaccinate the World
When United States Trade Representative Katherine Tai announced this past May that the U.S. would support the TRIPS waiver on COVID-19 vaccines at the World Trade Organization (WTO), we at the Revolving Door Project celebrated the administration’s decision as “a transformative, hopeful event.” The waiver proposal calls on the WTO’s Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council to suspend intellectual-property protections on COVID-19 therapeutics, diagnostics, and vaccines to ensure materials necessary for combating the pandemic are “available promptly, in sufficient quantities and at affordable price to meet global demand.”
September 24, 2021
Biden Administration’s Inaction on Vaccine Equity is Cowardly and Shameful
“Over four months after announcing its support for the COVID-19 TRIPS Waiver, the Biden administration’s once promising step towards achieving vaccine equity is proving to be little more than an empty promise. Officials across the administration are cowering in the face of Big Pharma’s insatiable appetite for profit rather than pursuing one of many paths to rapidly ensure equitable access to vaccines worldwide.”
April 16, 2021
Break Big Pharma's Stranglehold On COVID-19 Vaccines With Existing Powers, 16 Groups Tell Biden Admin
A coalition of 16 organizations called on Secretary of Commerce Gina Raimondo and COVID-19 Response Coordinator Jeffrey Zients to maximally use the executive branch’s existing powers to end the pharmaceutical industry’s stranglehold on supply on COVID-19 vaccines in an open letter today.
April 14, 2021
Big Pharma's Coils Around COVID-19 Vaccines Likely Protected By Raimondo, Zients, Ricchetti
The world deserves to know exactly who is responsible for the United States not yet supporting a waiver for intellectual property rights on COVID-19 vaccine production.
March 01, 2021
Zients Must Open-Source Vaccines To Prove Independence And Seriousness
As the United States approaches a full year of COVID-19-induced lockdowns, the Revolving Door Project and the Center for Economic and Policy Research called on the White House’s COVID-19 task force director Jeffrey Zients to demand that Pfizer, Moderna, and other American pharmaceutical firms open-source their COVID-19 vaccines.
December 17, 2020 | The American Prospect
Does Jeffrey Zients Have the Private-Sector Experience We Want in Government?
In an age of financialization and monopoly, ‘private-sector experience’ too often translates into those who successfully plunder for profit. Jeffrey Zients epitomizes that trend.